Themis Medicare’s VIRALEX effective against viral respiratory infections
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Company is investing more than €100 million in the expansion of the Halle site
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Lacosamide Injection is used to treat partial-onset seizures.
It is a two dose vaccine to be administered intramuscularly at 28 days apart
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Subscribe To Our Newsletter & Stay Updated